Challenges in addressing community concerns regarding clusters of multiple sclerosis and potential environmental exposures

Neuroepidemiology

Volumn 23, Issue 5, 2004, Pages 211-216

  Williamson, Dhelia M ^a   Henry, Judy P ^b  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

^b TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

Cluster investigations; Environmental exposure; Multiple sclerosis

Indexed keywords

COMMUNITY DYNAMICS; DISEASE ACTIVITY; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; GOVERNMENT; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PREVALENCE; PUBLIC HEALTH SERVICE; REVIEW; UNITED STATES;

CLUSTER ANALYSIS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIPLE SCLEROSIS; PUBLIC HEALTH PRACTICE; PUBLIC RELATIONS; UNITED STATES;

EID: 4444363716     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079945     Document Type: Review

References (40)

1. Joy JE, Johnson J Jr (eds): Institute of Medicine - Multiple Sclerosis: Current Status and Strategies for the Future. Washington, National Academy Press, 2001. Available from URL: http://books.nap.edu/books/0309072859/html
2. Hauser S: Multiple sclerosis and other demyelinating diseases; in Isselbacher KJ, Martin JB (eds): Harrison's Principles of Internal Medicine. New York, McGraw-Hill, 1994, pp 2289-2295.
3. Sadovnick AD, Dyment D, Ebers GC: Genetic epidemiology of multiple sclerosis. Epidemiol Rev 1997;19:99-106.
4. Hogancamp WE, Rodriguez M, Weinshenker BG: The epidemiology of multiple sclerosis. Mayo Clin Proc 1997;72:871-878.
5. Kesselring J: Multiple Sclerosis. Cambridge/UK, Cambridge University Press, 1997.
6. Schwartz RS: Autoimmunity and autoimmune diseases; in Paul WE (ed): Fundamental Immunology. New York, Raven Press, 1993, pp 1079-1080.
7. Helmick CG, Wrigley M, Zack MM, Bigler WJ, Lehman JI, Janssen RS, Hartwig CE, Witte JJ: Multiple sclerosis in Key West, Florida. Am J Epidemiol 1989;130:935-949.
8. Hoffman RE, Zack MM, Davis LE, Burchfiel CM: Increased incidence and prevalence of multiple sclerosis in Los Alamos County, New Mexico. Neurology 1981;31:1489-1492.
9. Hopkins RS, Indian RW, Pinnow E, Conomy J: Multiple sclerosis in Galion, Ohio: Prevalence and results of a case-control study. Neuroepidemiology 1991;10:192-199.
10. Centers for Disease Control and Prevention: Guidelines for investigating clusters of health events. MMWR 1990;39(RR-11).
11. Noonan CW, Kathman SJ, White MC: Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002;58:136-138.
12. Baum HM, Rothschild BB: The incidence and prevalence of reported multiple sclerosis. Ann Neurol 1981;10:420-428.
13. Wynn DR, Rodriguez M, O'Fallen M, Kurland LT: A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990;40:780-786.
14. Kurtzke JF: Multiple sclerosis: Changing times. Neuroepidemiology 1991;10:1-8.
15. Kurtzke JF: Geography in multiple sclerosis. J Neurol 1977;215:1-26.
16. Hernan MA, Olek MJ, Ascherio AJ: Geographic variation of multiple sclerosis incidence in two prospective studies of US women. Neurology 1999;53:1711-1718.
17. Poser CM: The epidemiology of multiple sclerosis: A general overview. Ann Neurol 1994; 36(suppl 2):180-193.
18. Wadia NH, Bhatia K: Multiple sclerosis prevalence in the Zoroastrians (Parsis) of India. Ann Neurol 1990;28:177-179.
19. Agency for Toxic Substances and Disease Registry: El Paso multiple sclerosis cluster investigation, El Paso, El Paso County, Texas. Atlanta, US Department of Health and Human Services, 2002.
20. Poser CM, Paty DW, Scheinberg LC, McDonald WI, Davis FA, Ebers GC et al: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-231.
21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
22. Stein EC, Schiffer RB, Hall WJ, Young N: Multiple sclerosis and the workplace: Report of an industry-based cluster. Neurology 1987;37:1672-1677.
23. Eastman R, Sheridan J, Poskanzer DC: Multiple sclerosis clustering in a small Massachusetts community, with possible common exposure 23 years before onset. N Engl J Med 1973;209:793-794.
24. Koch MJ, Reed D, Stern R, Brody JA: Multiple sclerosis: A cluster in a small northwestern United States community. JAMA 1974;228:1555-1557.
25. Kahana E: Epidemiologic studies of multiple sclerosis: A review. Biomed Phamacother 2000;54:100-102.
26. Marrie RA, Wolfson SC, Sturkenboom MC, Gout O, Heinzlef O, Roullet E, Abenhaim L: Multiple sclerosis and antecedent infections. Neurology 2000;54:2307-2310.
27. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Eng J Med 2000;343:938-952.
28. Willer CJ, Ebers GC: Susceptibility to multiple sclerosis: Interplay between genes and environment. Curr Opin Neurol 2000;13:241-247.
29. Minden SL, Marker WD, Harrold LN, Dor A: Multiple sclerosis: A statistical portrait. National Multiple Sclerosis Society, 1993.
30. Weinshenker BG: Epidemiology of multiple sclerosis. Neuroepidemiology 1996;14:291-308.
31. The Multiple Sclerosis Genetics Group: A complex genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996;13:241-247.
32. Compston A: The genetics of multiple sclerosis. J Neurovirol 2000;6:S5-S9.
33. Dyment DA, Sadnovick AD, Ebers GC: Genetics of multiple sclerosis. Hum Mol Genet 1997;6:1693-1698.
34. Noseworthy JH: Progress in determining the causes and treatment of multiple sclerosis. Nature 1999;399:A40-A47.
35. Casetta I, Granieri E: Clinical infections and multiple sclerosis: Contribution from analytical epidemiology. J Neurovirol 2000;6(suppl 2):147-151.
36. Hernan MA, Zhang M, Lipworth L, Okel MJ, Ascherio A: Multiple sclerosis and age at infection with common viruses. Epidemiology 2001;12:301-306.
37. Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM: Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344:327-332.
38. Ascherio A, Munch M: Epstein-Barr virus and multiple sclerosis. Epidemiology 1999;11:220-223.
39. Haahr S, Munch M: The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus. J Neurovirol 2000;6(suppl 2):76-79.
40. Jacobson DL, Gange SJ, Rose NR, Graham N: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-243.